Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports.

Journal of medical case reports - 25 Oct 2021

Razzaghy-Azar Maryam, Nourbakhsh Mitra, Talea Ali, Mohammad Amoli Mahsa, Nourbakhsh Mona, Larijani Bagher

Abstract excerpt

BACKGROUND: Permanent neonatal diabetes mellitus (PNDM) presents with dehydration and hyperglycemia, which usually occurs during the first 12 months of life. Activating mutations of beta-cell adenosine triphosphate-sensitive potassium [KATP] channel subunits that cause opening of the channel are associated with PNDM. Some patients with PNDM respond to administration of a sulfonylurea derivative, which has long...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Benzamides
Share to Carbamates

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus

Share to Hypoglycemic Agents

Share to Mutation

Share to Piperidines

Source

Open in PubMed Open full text

Identifiers

PMID: 34696808
DOI: 10.1186/s13256-021-03052-5
PMCID: PMC8543822

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports.PMID 34696808Read ↗

Case report: A 10-year prognosis of neonatal diabetes caused by a novel INS gene mutation.Semantic proximity Read ↗

Familial permanent neonatal diabetes with KCNJ11 mutation and the response to glyburide therapy--a three-year follow-up.Semantic proximity Read ↗

Neonatal diabetes mellitus: a disease linked to multiple mechanisms.Semantic proximity Read ↗

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.Semantic proximity Read ↗

Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2.Semantic proximity Read ↗

Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up.Semantic proximity Read ↗

Minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births.Semantic proximity Read ↗

Three cases of permanent neonatal diabetes mellitus: genotypes and management outcome.Semantic proximity Read ↗

Glibenclamide unresponsiveness in a Brazilian child with permanent neonatal diabetes mellitus and DEND syndrome due to a C166Y mutation in KCNJ11 (Kir6.2) gene.Semantic proximity Read ↗

[Permanent neonatal diabetes with known genetic background: oral drugs in treatment of childhood diabetes].Semantic proximity Read ↗

Neonatal diabetes due to homozygous INS gene promoter mutations: Highly variable phenotype, remission and early relapse during the first 3 years of life.Semantic proximity Read ↗

Permanent neonatal diabetes mellitus in Jordan.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.